Cargando…
Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
BACKGROUND: With 2.5 million new HIV infections per year, effective preventive methods against HIV are urgently needed, especially in sub-Saharan Africa. MDP301 is an ongoing trial of the vaginal microbicide PRO 2000/5 being conducted by the Microbicides Development Programme. The main objective of...
Autores principales: | Nunn, Andrew, McCormack, Sheena, Crook, Angela M, Pool, Robert, Rutterford, Clare, Hayes, Richard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774685/ https://www.ncbi.nlm.nih.gov/pubmed/19860888 http://dx.doi.org/10.1186/1745-6215-10-99 |
Ejemplares similares
-
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
por: McCormack, Sheena, et al.
Publicado: (2010) -
Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania
por: Vallely, Andrew, et al.
Publicado: (2009) -
A Mixed Methods and Triangulation Model for Increasing the Accuracy of Adherence and Sexual Behaviour Data: The Microbicides Development Programme
por: Pool, Robert, et al.
Publicado: (2010) -
Assessing the Accuracy of Adherence and Sexual Behaviour Data in the MDP301 Vaginal Microbicides Trial Using a Mixed Methods and Triangulation Model
por: Pool, Robert, et al.
Publicado: (2010) -
The Implications of Post-coital Intravaginal Cleansing for the Introduction of Vaginal Microbicides in South Africa
por: Gafos, Mitzy, et al.
Publicado: (2013)